Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

VCA Graft Rejection & Immunosuppression Biomarker Analysis

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, titled VCA Graft Rejection and Immunosuppression Biomarker Analysis, is issued by the Department of the Army USAMRRA under the Department of Defense. The project focuses on the identification and validation of prognostic or diagnostic biomarkers for prime contractors supporting Defense Health Agency research. The primary scope of work involves analyzing human clinical samples to monitor immunosuppression levels and VCA graft rejection through the use of high-sensitivity assay equipment. To ensure compliance with human subject research standards, the contractor must maintain CLIA certification and obtain IRB approval. The expected deliverables include technical reports, assay results, and validated biomarker profiles. The contract is categorized under NAICS code 621511 and was posted on May 29, 2026.

General Info

USAMRRA subcontract for analyzing biomarkers to monitor VCA graft rejection and immunosuppression.

Agency

Department Of Defense → Department Of The Army -- Usamraa

NAICS

621511 - Medical Laboratories

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of HT942526RTRPCA.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Reconstructive Transplant, Concept Award

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedMay 29

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Department Of The Army -- Usamraa

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → Department Of The Army -- Usamraa

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Performs identification and validation of prognostic or diagnostic biomarkers for prime contractors on Defense Health Agency (DHACA) research projects. Analyzes human clinical samples to monitor VCA graft rejection and immunosuppression levels using high-sensitivity assay equipment. Requires CLIA certification and IRB approval for human subject research. Delivers validated biomarker profiles, assay results, and technical reports.

Similar Contracts

Same NAICS industry code

Comprehensive Drug Screening and Laboratory AnalysisThis subcontract for Comprehensive Drug Screening and Laboratory Analysis involves providing clinical collection and laboratory analysis of biological samples for prime contractors on ALEA drug screening projects. The scope of work includes conducting hair analysis and Non-NIDA Panel 8 testing, utilizing specialized clinical laboratory equipment and strict Chain of Custody forms to ensure accuracy and compliance. Beyond technical analysis, the provider is responsible for the medical review of non-negative results and the delivery of confirmed drug screen reports. The contract also encompasses the management of centralized billing and administrative functions to support the overall drug screening operation for the Alabama Personnel agency.

POSTED

DEADLINE

Personnel- ALEA Drug Screening

Solicitation # SRC0000037283

This solicitation, identified as SRC0000037283, is for the provision of a comprehensive drug testing and screening program for the Alabama Law Enforcement Agency (ALEA). The scope of work includes the administration of various drug screens, such as hair analysis via LabCorp PSC, non-NIDA panel 8 tests, and saliva testing, along with the provision of test kits. Additionally, the contractor is responsible for providing a two-hour online reasonable suspicion training session compliant with DOT and Drug Free Workplace regulations, managing random selection processes, and performing medical reviews of non-negative results. The contract is processed as a Quick Quote through the Alabama Buys system, with the State of Alabama reserving the right to evaluate bids based on cost realism and price reasonableness. The resulting contract may be renewed annually for a total period of up to five years, with a total cost cap of 25,000 dollars. Key compliance requirements include mandatory enrollment in E-Verify for suppliers with employees in Alabama, registration with the Alabama Secretary of State for foreign entities, and strict adherence to state tax certifications under Section 41-4-142 of the Code of Alabama 1975. Legal venue for any disputes is established in the City of Montgomery, Alabama. Suppliers must submit all responses electronically via the Alabama Buys portal and may be required to provide professional licenses, certificates of insurance, and manufacturer authorizations following the bid opening.

POSTED

DEADLINE

Remote Alcohol Testing ProviderThis subcontract agreement establishes a partnership for the provision and management of remote alcohol testing equipment for prime contractors working on City of Avondale City Court projects. The selected provider is responsible for distributing remote breathalyzers to defendants, monitoring results through cloud-based reporting systems, and delivering detailed testing logs and violation reports directly to the court. To ensure compliance, the provider must maintain certification for the specific testing equipment used and strictly adhere to all court-approved standards. This engagement falls under NAICS code 621511 and is managed by the City Court in Arizona, with a response deadline set for November 20, 2026.

POSTED

DEADLINE

Drug and Alcohol Testing ServicesThis subcontract for Drug and Alcohol Testing Services supports prime contractors on Department of Justice Residential Reentry Center projects. The selected provider will be responsible for performing unscheduled urinalysis and laboratory-based screenings, which include collecting urine samples and utilizing FDA-licensed test cups for point-of-collection screening followed by formal laboratory confirmation. All activities must strictly adhere to the procedures established by the BOP Drug and Alcohol Testing Surveillance Program to ensure the delivery of verified results and reports. The opportunity is categorized under NAICS code 621511 and is associated with the Residential Reentry - Co. The response deadline for this requirement is December 22, 2026, with the place of performance located in zip code 23661.

Residential Reentry - Co

POSTED

DEADLINE

Accredited DNA Testing ProviderThis subcontract for the City and County of Swansea requires an accredited DNA testing provider to support safeguarding and social care projects. The selected provider will be responsible for the end-to-end testing process, including identity verification, the collection of buccal swab samples, and strict chain of custody management. Technical requirements include performing DNA profiling and comparison within accredited sequencing laboratories to ensure the highest standards of accuracy. Beyond laboratory analysis, the provider must deliver formal verified reports and provide expert witness testimony for court hearings. This opportunity was posted on October 20, 2026, with a response deadline of November 16, 2026. The services fall under NAICS code 621511, focusing on specialized medical diagnostic services to support legal and social care outcomes.

City & County of Swansea

POSTED

DEADLINE

Accredited Drug and Alcohol Testing ProviderThis subcontract agreement establishes an Accredited Drug and Alcohol Testing Provider to support prime contractors on statutory projects for the City and County of Swansea. The selected provider is responsible for the end-to-end testing process, including field or clinic-based sample collection, the management of a secure chain of custody to ensure legal admissibility, and comprehensive laboratory analysis. To maintain these standards, the provider must utilize accredited laboratory facilities and secure transport containers. Beyond technical testing, the provider is required to deliver professional test reports and offer expert interpretation of results. This scope of work extends to legal support, requiring the provider to furnish expert witness testimony during legal proceedings. Interested parties must respond by November 16, 2026, in accordance with the solicitation posted on October 20, 2026.

City & County of Swansea

POSTED

DEADLINE

Framework Agreement for DNA, Drug and Alcohol Testing Services

Solicitation # CCS/26/257

The City and County of Swansea is establishing a Framework Agreement under solicitation CCS/26/257 for accredited testing services to support statutory functions, including social care, safeguarding, and legal proceedings. The framework is divided into two lots: Lot 1 for Drug and Alcohol Testing Services and Lot 2 for DNA Testing Services, with each lot having an estimated value of 350,000 GBP excluding VAT. The scope of work includes identity verification for DNA testing and expert witness support where required. The agreement is scheduled to run from January 11, 2027, to January 10, 2032, with an option to extend for an additional 24 months through January 10, 2034. A maximum of six suppliers may be appointed to the framework, and the council may award contracts through either direct award or mini-competition. This procurement is designated as a light touch regime and is open to small and medium-sized enterprises as well as voluntary, community, and social enterprises. Interested parties must submit their tenders electronically via the eTenderWales portal by November 16, 2026, at 12:00pm. Submissions are accepted in both English and Welsh, and bidders may apply for one or both available lots.

City & County of Swansea

POSTED

DEADLINE

STAT Clinical Laboratory Testing & AnalysisThis subcontract for STAT Clinical Laboratory Testing and Analysis supports prime contractors on Department of Veterans Affairs healthcare system projects. The selected provider will perform 24/7/365 analysis and monitoring of patient specimens, ensuring immediate notification of critical results and the delivery of final written reports within five working days. To qualify, the provider must employ board-certified pathologists and maintain a NYS DOH Clinical Laboratory Permit and a CLIA license. Additionally, the facility must hold accreditation from either the College of American Pathologists or the Joint Commission. This opportunity is categorized under NAICS code 621511 and is managed by the Department of Veterans Affairs Network Contract Office 02.

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Q301--FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334)

Solicitation # 36C24227Q0069

The Department of Veterans Affairs VISN 2 Network Contracting Office intends to award a firm fixed-price contract for STAT laboratory testing services at the Syracuse VA Medical Center. The proposed contract structure includes a base period followed by four option periods. The government intends to sole source this requirement to University Pathologists Laboratories under FAR 6.302-1(a)(2), though this special notice serves as market research to identify other capable providers, including various small business socioeconomic categories. The scope of work involves the 24/7, 365-day-a-year analysis, monitoring, and reporting of clinical and surgical specimens, utilizing advanced methods such as electron microscopy and molecular studies. Key operational requirements include picking up specimens within 30 minutes of a request and delivering final written reports within five working days. Critical results require immediate notification to authorized providers. To be eligible, the contractor must employ board-certified pathologists and accredited technologists and maintain mandatory certifications, including a NYS Department of Health Clinical Laboratory Permit, a CLIA license, and CAP or Joint Commission accreditation. This acquisition falls under NAICS code 621511. Interested parties must provide documentation of their technical expertise and socioeconomic status to the contracting officer within 10 calendar days of the notice publication.

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Specialized Cell Source & Biobank SupplyThis subcontract opportunity with the National Institutes of Health, under the Department of Health and Human Services, focuses on the supply and qualification of human cell sources and biological resources for prime contractors working on NIAID infectious disease projects. The selected provider will be responsible for sourcing, characterizing, and qualifying primary cells or human cell lines that represent diverse human variability, utilizing genomic characterization tools and cryogenic storage to ensure quality and stability. The scope of work includes performing essential qualification of cell sources as a project benchmark and delivering fully characterized tissue samples or cell lines. Interested parties should note that the response deadline is January 29, 2027, and the project falls under NAICS code 621511.

National Institutes Of Health

POSTED

DEADLINE

Forensic Toxicology Laboratory ServicesThis subcontract for Forensic Toxicology Laboratory Services supports Florida Department of Transportation drug testing projects by providing professional analysis of collected drug and alcohol specimens for prime contractors. The selected provider is responsible for analyzing specimens for controlled substances, processing split samples, and delivering all test results and reports to the Medical Review Officer. To qualify, the provider must operate a certified forensic toxicology laboratory that adheres to all USDOT and FMCSA standards. This opportunity falls under NAICS code 621511, with a response deadline set for November 4, 2026.

Florida Department of Transportation

POSTED

DEADLINE

Controlled Substances and Alcohol Use Testing

Solicitation # DOT-RFP-27-9020-JM

The Florida Department of Transportation is soliciting competitive proposals under solicitation number DOT-RFP-27-9020-JM for third-party controlled substances and alcohol use testing program management services. The selected vendor will be responsible for administering testing for CDL drivers and other department employees, including random selection and testing using scientifically valid methods, providing Substance Abuse Professional services for rehabilitation monitoring, and maintaining 24-hour emergency collection coordination. The scope of work requires strict adherence to federal regulations, including USDOT 49 CFR Part 40 and FMCSA 49 CFR Part 382, as well as the Florida Drug-Free Workplace Act. Deliverables include a secure, password-protected website for results and statistical reporting, with monthly itemized invoicing submitted through the MyFloridaMarketplace system. The procurement process requires a two-part submission consisting of a technical proposal and a price proposal. To be considered responsive, proposers must achieve a minimum average score of 70 points on the technical evaluation, which is weighted across a management plan, work plan, executive summary, and technical plan. The contract is planned for performance across multiple fiscal years from 2027 through 2031. Eligible bidders must be registered in MyFloridaMarketplace, authorized to do business in Florida, and compliant with scrutinized companies lists and non-discrimination statutes. Evaluation is based on the grand total of tests, fees, and services, and the department reserves the right to conduct on-site reviews of facilities and qualifications prior to contract execution.

Florida Department of Transportation

POSTED

DEADLINE

More opportunities from Department Of Defense → Department Of The Army -- Usamraa

Same awarding agency

Data Management and Research Sharing Plan DevelopmentThe contract seeks the design and implementation of a secure, compliant data management plan tailored for biomedical research, with a strong emphasis on preserving data integrity, adhering to FAIR principles—findable, accessible, interoperable, and reusable—and meeting federal requirements for data sharing. The plan must ensure that all research data is handled in a manner that supports long-term preservation, ethical use, and regulatory compliance, particularly under Department of Defense standards. The subcontractor will be responsible for developing structured policies and technical workflows that align with evolving federal mandates, enabling seamless data sharing while maintaining rigorous security protocols to protect sensitive biomedical information. The initiative is managed by the Department of the Army through USAMRAA under the broader Department of Defense, with the NAICS code 518210 indicating its focus on data processing and hosting services. The opportunity is open as a subcontract, with responses due by November 4, 2026. While the physical place of performance and point of contact are not specified, the work must be executed to meet federal compliance timelines and deliverables without reliance on proprietary or non-standard frameworks. The goal is to establish a scalable, audit-ready data infrastructure that supports ongoing and future biomedical research initiatives under federal oversight.

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

DEADLINE

VCA Preservation & Perfusion Modality DevelopmentThis subcontract, titled VCA Preservation and Perfusion Modality Development, supports Defense Health Agency research projects through the Department of the Army USAMRRA. The primary objective is to develop and test strategies for preserving vascularized composite allografts, specifically focusing on implementing active perfusion modalities and static preservation to reduce ischemia-reperfusion injury. The technical execution of the contract requires the use of specialized equipment, including temperature-controlled chambers and perfusion pumps. The successful party is responsible for delivering comprehensive technical reports that detail the efficacy of these methods and provide optimized perfusion protocols.

Measuring, Dispensing, and Other Pumping Equipment Manufacturing

POSTED

DEADLINE

Clinical Graft Monitoring Tool PrototypingThis subcontract opportunity with the Department of the Army USAMRRA involves the development of assays, devices, and technology for clinical graft monitoring in support of Defense Health Agency research projects. The selected provider will prototype monitoring devices and integrate biomarkers into tools specifically designed for the human use factors associated with vascularized composite allotransplantation recipients. The project requires the delivery of a functional prototype or a validated assay kit. To qualify, providers must possess bio-engineering facilities and adhere to ISO 13485 or FDA Quality System Regulation standards. The work falls under NAICS code 541715 and is focused on advancing clinical monitoring capabilities for the Department of Defense.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

VCA Clinical Outcome Assessment ToolsThis subcontract, titled VCA Clinical Outcome Assessment Tools, is issued by the Department of the Army USAMRRA under the Department of Defense. The primary objective is to develop tools and metrics to measure the success and functional outcomes of VCA procedures for prime contractors working on Defense Health Agency research projects. This involves the design of both quantitative and qualitative tools specifically focused on quality of life assessments and return-to-duty metrics. The project requires strict adherence to 32 CFR 219.104 regulations regarding human subject research. The final deliverable for this effort is a validated scoring system or outcome measurement tool. The contract is categorized under NAICS code 541712 and was posted on May 29, 2026.

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

POSTED

DEADLINE

DoW Reconstructive Transplant, Concept Award

Solicitation # HT942526RTRPCA

The Defense Health Agency Contracting Activity is soliciting applications for the fiscal year 2026 Reconstructive Transplant Research Program Concept Award under solicitation HT942526RTRPCA. This program supports the exploration of highly innovative new concepts or untested theories that address critical problems in reconstructive transplantation, specifically those aligned with FY26 RTRP Focus Areas. The award is designed for high-risk, high-reward research that introduces new paradigms or creative perspectives, and it explicitly excludes clinical trials and incremental advances based on existing data. Early-career investigators at or above the postdoctoral fellow level are encouraged to apply. Funding is capped at 200,000 dollars per award for a maximum period of performance of 18 months, with an overall program appropriation of 12 million dollars. The selection process involves a two-tier review consisting of a peer review for technical merit followed by a programmatic review for relevance to military health and program priorities. Applicants must maintain active registrations in SAM.gov, eBRAP.org, and Grants.gov. Key submission requirements include a three-page Statement of Work, a one-page Innovation Statement, and a one-page Post-Award Transition Plan. All applications must be submitted by the specified deadlines, with full applications from extramural organizations required to go through the Grants.gov Workspace. Special attention is required for the disclosure of foreign affiliations of key personnel and the approval of the DHA R&D Office of Research and Regulatory Compliance for any research involving human or animal subjects.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Statistical Analysis and Study DesignThis subcontract opportunity with the Department of the Army USAMRAA involves providing specialized biostatistical expertise to support prime contractors on DHA and DoD research projects. The selected provider will be responsible for developing statistical frameworks for hypotheses, determining sample sizes, and conducting power calculations for behavioral health or biomedical outcomes. Technical proficiency in SAS, R, or SPSS is required to deliver the Statistical Analysis Plan and the Final Data Analysis Report. Qualified candidates must hold an advanced degree in Statistics or Biostatistics to meet the professional requirements of the role. The project falls under NAICS code 541690 and is focused on high-level study design and statistical analysis to ensure the integrity of research outcomes for the Department of Defense.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Clinical Trial Management and CoordinationThis subcontract for Clinical Trial Management and Coordination supports the Department of Defense and the Department of the Army USAMRAA by providing day-to-day management of clinical trials for prime contractors on DHA research projects. The scope of work includes the development and execution of Study Management Plans, the coordination of multi-institutional data transfers, and the management of imaging products and specimen sharing. The contractor is responsible for ensuring all activities adhere to Good Clinical Practice standards and 45 CFR 46.102 using clinical coordinating center infrastructure. Key deliverables for this engagement include the finalized Study Management Plan and comprehensive data transfer logs. The project falls under NAICS code 541714 and was posted on May 21, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Clinical Ethics and Patient AdvocacyThis subcontract, titled Clinical Ethics and Patient Advocacy, supports prime contractors on DHA and DoD research projects by providing essential ethical guidance and patient advocacy. The scope of work includes reviewing study protocols for ethical compliance and developing strategic advice for patient recruitment and retention. Key deliverables consist of Ethics Review Reports and Patient Advocacy Guidance. The position requires specialized qualifications, specifically Clinical Ethicist certification or recognized Patient Advocacy credentials. This effort is managed under the Department of the Army USAMRAA within the Department of Defense, falling under NAICS code 541690.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Intervention Material SupplyThis subcontract, titled Intervention Material Supply, involves the provision of drugs, medical devices, and surgical tools to prime contractors supporting DHA and DoD research projects. The selected provider is responsible for manufacturing and delivering interventions that demonstrate proven safety, stability, and dosing consistency. To ensure quality and compliance, the contractor must utilize GMP-certified facilities and maintain ISO 13485 certification for all medical devices. Deliverables include the physical intervention materials accompanied by formal Certificates of Analysis. This opportunity is associated with the Department of the Army USAMRRA under NAICS code 325412.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Regulatory Compliance and Application SupportThe Regulatory Compliance and Application Support subcontract, issued by the Department of the Army under the Department of Defense, focuses on the preparation and submission of regulatory applications for prime contractors involved in DHA and DoD research projects. The scope of work includes managing FDA sponsor applications, ensuring strict adherence to 45 CFR 46.102, and creating clinical monitoring plans designed to mitigate operational risks. To qualify, personnel must possess a Regulatory Affairs Certification or demonstrate equivalent expertise in FDA guidelines. The primary deliverables for this engagement are comprehensive regulatory submission packages and detailed Clinical Monitoring Plans. This effort falls under NAICS code 541690 and is managed through the USAMRAA office.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Clinical Support Tool & Knowledge Product DevelopmentThis subcontract for Clinical Support Tool and Knowledge Product Development supports prime contractors on Defense Health Agency projects through the creation of clinical practice guidelines, provider training materials, and patient-facing tools. The scope of work includes developing patient brochures, scientific journal publications, and medical simulations, all of which must adhere to strict medical publication standards and clinical guideline protocols. The project requires the use of specialized medical writing software and instructional design tools to deliver finalized published guidelines and software applications. This effort is managed under the Department of the Army within the Department of Defense, falling under NAICS code 541511.

Custom Computer Programming Services

POSTED

DEADLINE

Pre-clinical Animal Model TestingThis subcontract for Pre-clinical Animal Model Testing supports the Department of the Army and the Defense Health Agency by conducting animal studies to determine relevance to human orthopaedic biology. The scope of work includes managing specific animal species and strains, performing surgical or therapeutic procedures, and implementing necessary study controls. The selected provider must possess veterinary surgical facilities and animal housing, as well as maintain required IACUC approval and certification. The primary deliverables for this engagement are animal study data and biological impact reports. This effort falls under NAICS code 541720 and is designed to assist prime contractors in validating medical research through rigorous pre-clinical testing.

Research and Development in the Social Sciences and Humanities

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS